Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial

Hepatology. 2002 Jan;35(1):238-9. doi: 10.1053/jhep.2002.30276.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • HIV Infections / complications*
  • Hepacivirus / physiology*
  • Hepatitis B / complications
  • Hepatitis B / virology
  • Hepatitis B virus / physiology*
  • Hepatitis C / complications
  • Hepatitis C / virology
  • Humans
  • Interleukin-2 / therapeutic use*
  • Virus Replication / drug effects*

Substances

  • Interleukin-2